Literature DB >> 8878056

Pharmacokinetic and alpha 1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport.

H Russ1, B Friedgen, B Königs, C Schumacher, K H Graefe, E Schömig.   

Abstract

1,1'-Diethyl-2,2'-cyanine (decynium22) and 1,1'-diisopropyl-2,4'-cyanine (disprocynium24) are highly potent inhibitors of the extraneuronal monamine transporter. When given as i.v. bolus injections (4 mumol kg-1) to anaesthetized rabbits, both drugs elicited a transient fall in blood pressure without altering heart rate. The observed maximum fall in diastolic blood pressure was 59% after decynium22 and 43% after disprocynium24 administration. The pharmacokinetics of decynium22 and disprocynium24 were similar; they were characterized by short half-lives for elimination (8.2 and 4.5 min, respectively) and very high plasma clearances (173 and 180 ml kg-1 min-1, respectively). The mechanism underlying the blood pressure-lowering effect of decynium22 was explored in the isolated incubated rabbit aorta. Decynium22 antagonized the noradrenaline-induced contraction; the pA2 for this interaction was 7.6, and the slope of the corresponding Schild plot was unity. In a membrane preparation from rat myocardium, decynium22 as well as disprocynium24 inhibited the specific binding of [125I]-2-[beta-(4-hydroxy-3-iodophenyl)-ethylaminomethyl]- tetralone (125I-HEAT), a selective ligand to alpha 1-adrenoceptors. The Ki's were 5.3 and 240 mumol l-1 for decynium22 and disprocynium24, respectively. The type of binding inhibition by decynium22 was competitive. It is concluded that the two inhibitors of extraneuronal monoamine transport decynium22 and disprocynium24 lower blood pressure by blocking alpha 1-adrenoceptors. A comparison of their potencies in blocking extraneuronal monoamine transport and alpha 1-adrenoceptors clearly indicates that disprocynium24 is more suitable for studies designed to determine the role of extraneuronal monoamine transport in vivo. Considering its very fast elimination kinetics, disprocynium24 must be administered by constant rate-infusions in order to avoid large fluctuations of plasma levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878056     DOI: 10.1007/bf00171057

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit.

Authors:  B Friedgen; R Wölfel; H Russ; E Schömig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 2.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

3.  Subtypes of alpha 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery.

Authors:  I Muramatsu; S Kigoshi; T Ohmura
Journal:  Jpn J Pharmacol       Date:  1991-12

Review 4.  Extraneuronal transport of noradrenaline.

Authors:  E Schömig
Journal:  J Auton Pharmacol       Date:  1994-02

5.  [125I]-HEAT, a selective, high-affinity, high specific activity ligand for alpha 1-adrenoceptors.

Authors:  H Glossmann; F Lübbecke; P Bellemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

6.  The force driving the extraneuronal transport mechanism for catecholamines (uptake2).

Authors:  E Schömig; J Babin-Ebell; H Russ; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

7.  Prazosin depression of baroreflex function in hypertensive man.

Authors:  E H Sasso; D T O'Connor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Classification of alpha 1-adrenoceptor subtypes.

Authors:  M C Michel; B Kenny; D A Schwinn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline transport inhibitors: synthesis, detection, and biological activity.

Authors:  H Russ; W Engel; E Schömig
Journal:  J Med Chem       Date:  1993-12-24       Impact factor: 7.446

View more
  6 in total

1.  Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.

Authors:  Rebecca E Horton; Deana M Apple; W Anthony Owens; Nicole L Baganz; Sonia Cano; Nathan C Mitchell; Melissa Vitela; Georgianna G Gould; Wouter Koek; Lynette C Daws
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

2.  Evaluation of the antidepressant therapeutic potential of isocyanine and pseudoisocyanine analogues of the organic cation decynium-22.

Authors:  Anwen M Krause-Heuer; Rheaclare Fraser-Spears; Jeremy C Dobrowolski; Mark E Ashford; Naomi A Wyatt; Maxine P Roberts; Georgianna G Gould; Wai-Ching Cheah; Clarissa K L Ng; Mohan Bhadbhade; Bo Zhang; Ivan Greguric; Nial J Wheate; Naresh Kumar; Wouter Koek; Paul D Callaghan; Lynette C Daws; Benjamin H Fraser
Journal:  Eur J Med Chem       Date:  2017-06-07       Impact factor: 6.514

3.  The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit.

Authors:  B Friedgen; R Wölfel; H Russ; E Schömig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  Cardiovascular afferents cause the release of 5-HT in the nucleus tractus solitarii; this release is regulated by the low- (PMAT) not the high-affinity transporter (SERT).

Authors:  Patrick S Hosford; Julian Millar; Andrew G Ramage
Journal:  J Physiol       Date:  2015-02-19       Impact factor: 5.182

Review 5.  Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury?

Authors:  Cui Yang; George P H Leung
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

6.  High Affinity Decynium-22 Binding to Brain Membrane Homogenates and Reduced Dorsal Camouflaging after Acute Exposure to it in Zebrafish.

Authors:  Georgianna G Gould; Priscilla A Barba-Escobedo; Rebecca E Horton; Lynette C Daws
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.